FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Raymond Reilly

Research Profile

Chemicals & Drugs

Anatomy

Disorders

Breast Neoplasms

Living Beings

Co-author Network

Publications

TOP 3
Eva Razumienko; Lindsay Dryden; Deborah Scollard; Raymond M Reilly
MicroSPECT/CT imaging of co-expressed HER2 and EGFR on subcutaneous human tumor xenografts in athymic mice using (111)In-labeled bispecific radioimmunoconjugates.
Neil Vasdev; Douglass C Vines; Alan A Wilson; David E Green; Sylvain Houle; Patrick N McCormick; Kristin McLarty; Matthew D Moran; Raymond M Reilly
Positron-Emission Tomography Imaging of the TSPO with [(18)F]FEPPA in a Preclinical Breast Cancer Model.
Niladri Chattopadhyay; Yongkyu Luke Kwon; Eli Lechtman; Jean-Philippe Pignol; Zhongli Cai; Raymond M Reilly
Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Raymond Reilly (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Eva Razumienko; Lindsay Dryden; Deborah Scollard; Raymond M Reilly
MicroSPECT/CT imaging of co-expressed HER2 and EGFR on subcutaneous human tumor xenografts in athymic mice using (111)In-labeled bispecific radioimmunoconjugates.
Breast cancer research and treatment 2013;138(3):709-18.
2013: Neil Vasdev; Douglass C Vines; Alan A Wilson; David E Green; Sylvain Houle; Patrick N McCormick; Kristin McLarty; Matthew D Moran; Raymond M Reilly
Positron-Emission Tomography Imaging of the TSPO with [(18)F]FEPPA in a Preclinical Breast Cancer Model.
Cancer biotherapy & radiopharmaceuticals 2013;28(3):254-9.
2013: Niladri Chattopadhyay; Yongkyu Luke Kwon; Eli Lechtman; Jean-Philippe Pignol; Zhongli Cai; Raymond M Reilly
Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation.
Breast cancer research and treatment 2013;137(1):81-91.
2013: Amanda J Boyle; Peng Liu; Yijie Lu; Ghislaine Ngo Njock Mbong; Deborah A Scollard; Dirk Weinrich; Mitchell A Winnik; Raymond M Reilly
The effect of metal-chelating polymers (MCPs) for 111In complexed via the streptavidin-biotin system to trastuzumab Fab fragments on tumor and normal tissue distribution in mice.
Pharmaceutical research 2013;30(1):104-16.
2012: Eva J Razumienko; Deborah A Scollard; Raymond M Reilly
Small-animal SPECT/CT of HER2 and HER3 expression in tumor xenografts in athymic mice using trastuzumab Fab-heregulin bispecific radioimmunoconjugates.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(12):1943-50.
2012: Peng Liu; Yijie Lu; Raymond M Reilly; Amanda J Boyle; Mitchell A Winnik
Biotinylated polyacrylamide-based metal-chelating polymers and their influence on antigen recognition following conjugation to a trastuzumab Fab fragment.
Biomacromolecules 2012;13(9):2831-42.
2012: Aisha Fasih; Humphrey Fonge; Jeffrey V Leyton; Zhongli Cai; Susan J Done; Ilia Tikhomirov; Raymond M Reilly
¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer.
Breast cancer research and treatment 2012;135(1):189-200.
2012: Yijie Lu; Ansgar Niehoff; Raymond M Reilly; Dirk Weinrich; A J Boyle; Mokit Chau; Peng Liu; Mitchell A Winnik
Effect of pendant group structure on the hydrolytic stability of polyaspartamide polymers under physiological conditions.
Biomacromolecules 2012;13(5):1296-306.
2012: Bryan Hoang; Raymond M Reilly; Christine Allen
Block copolymer micelles target Auger electron radiotherapy to the nucleus of HER2-positive breast cancer cells.
Biomacromolecules 2012;13(2):455-65.
2012: Humphrey Fonge; Huang Huang; Raymond M Reilly; Deborah Scollard; Christine Allen
Influence of formulation variables on the biodistribution of multifunctional block copolymer micelles.
Journal of controlled release : official journal of the Controlled Release Society 2012;157(3):366-74.
2011: Kristin McLarty; JoAnne McLaurin; Matthew D Moran; Joydeep Mukherjee; Mark Nitz; Raymond M Reilly; Nesrin Sabha; Deborah A Scollard; Conrad Chan; Abhijit Guha; Sylvain Houle; Alan A Wilson; Neil Vasdev
Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice.
Nuclear medicine and biology 2011;38(7):953-9.
2011: Jeffrey Victor Leyton; Mark Minden; John E Dick; Catherine Gao; Meiduo Hu; Patricia V Turner; Raymond M Reilly
Auger electron radioimmunotherapeutic agent specific for the CD123+/CD131- phenotype of the leukemia stem cell population.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(9):1465-73.
2011: Deborah A Scollard; Conrad Chan; Claire M B Holloway; Raymond M Reilly
A kit to prepare (111)In-DTPA-trastuzumab (Herceptin) Fab fragments injection under GMP conditions for imaging or radioimmunoguided surgery of HER2-positive breast cancer.
Nuclear medicine and biology 2011;38(1):129-36.
2010: Helen Lee; Bryan Hoang; Humphrey Fonge; Raymond M Reilly; Christine Allen
In vivo distribution of polymeric nanoparticles at the whole-body, tumor, and cellular levels.
Pharmaceutical research 2010;27(11):2343-55.
2010: Helen Lee; Humphrey Fonge; Bryan Hoang; Raymond M Reilly; Christine Allen
The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles.
Molecular pharmaceutics 2010;7(4):1195-208.
2010: Danny L Costantini; Kristin McLarty; Helen Lee; Susan J Done; Katherine A Vallis; Raymond M Reilly
Antitumor effects and normal-tissue toxicity of 111In-nuclear localization sequence-trastuzumab in athymic mice bearing HER-positive human breast cancer xenografts.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(7):1084-91.
2010: Olayinka Akinlolu; Kathryn Ottolino-Perry; J Andrea McCart; Raymond M Reilly
Antiproliferative effects of 111In- or 177Lu-DOTATOC on cells exposed to low multiplicity-of-infection double-deleted vaccinia virus encoding somatostatin subtype-2 receptor.
Cancer biotherapy & radiopharmaceuticals 2010;25(3):325-33.
2010: Danny L Costantini; Daniela F Villani; Katherine A Vallis; Raymond M Reilly
Methotrexate, paclitaxel, and doxorubicin radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting radiotherapeutic agent (111)In-NLS-trastuzumab.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(3):477-83.
2010: Zhongli Cai; Jean-Philippe Pignol; Conrad Chan; Raymond M Reilly
Cellular dosimetry of (111)In using monte carlo N-particle computer code: comparison with analytic methods and correlation with in vitro cytotoxicity.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(3):462-70.
2010: Conrad Chan; Zhongli Cai; Ruifen Su; Raymond M Reilly
111In- or 99mTc-labeled recombinant VEGF bioconjugates: in vitro evaluation of their cytotoxicity on porcine aortic endothelial cells overexpressing Flt-1 receptors.
Nuclear medicine and biology 2010;37(2):105-15.
2010: Humphrey Fonge; Helen Lee; Raymond M Reilly; Christine Allen
Multifunctional block copolymer micelles for the delivery of 111In to EGFR-positive breast cancer cells for targeted Auger electron radiotherapy.
Molecular pharmaceutics 2010;7(1):177-86.
2009: Kristin McLarty; Aisha Fasih; Deborah A Scollard; Susan J Done; Douglass C Vines; David E Green; Danny L Costantini; Raymond M Reilly
18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(11):1848-56.
2009: Bart Cornelissen; Veerle Kersemans; Kristin McLarty; Lara Tran; Katherine A Vallis; Raymond M Reilly
In vivo monitoring of intranuclear p27(kip1) protein expression in breast cancer cells during trastuzumab (Herceptin) therapy.
Nuclear medicine and biology 2009;36(7):811-9.
2009: Kristin McLarty; Bart Cornelissen; Zhongli Cai; Deborah A Scollard; Danny L Costantini; Susan J Done; Raymond M Reilly
Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(8):1340-8.
2009: Raymond M Reilly
Aiming for a direct hit: combining molecular imaging with targeted cancer therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(7):1017-9.
2009: Bart Cornelissen; Veerle Kersemans; Kristin McLarty; Lara Tran; Raymond M Reilly
111In-labeled immunoconjugates (ICs) bispecific for the epidermal growth factor receptor (EGFR) and cyclin-dependent kinase inhibitor, p27Kip1.
Cancer biotherapy & radiopharmaceuticals 2009;24(2):163-73.
2009: Bryan Hoang; Helen Lee; Raymond M Reilly; Christine Allen
Noninvasive monitoring of the fate of 111In-labeled block copolymer micelles by high resolution and high sensitivity microSPECT/CT imaging.
Molecular pharmaceutics 2009;6(2):581-92.
2009: Zhongli Cai; Katherine A Vallis; Raymond M Reilly
Computational analysis of the number, area and density of gamma-H2AX foci in breast cancer cells exposed to (111)In-DTPA-hEGF or gamma-rays using Image-J software.
International journal of radiation biology 2009;85(3):262-71.
2009: Kristin McLarty; Bart Cornelissen; Deborah A Scollard; Susan J Done; Kathy Chun; Raymond M Reilly
Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.
European journal of nuclear medicine and molecular imaging 2009;36(1):81-93.
2008: J Liu; Deborah A Scollard; Raymond M Reilly; X Y Wu; M R Johnston
Effect of particle size on the lymphatic distribution of 111Indium-aminopolystyrene through intrapleural administration.
Lymphology 2008;41(4):153-60.
2008: Danny L Costantini; Katherine Bateman; Kristin McLarty; Katherine A Vallis; Raymond M Reilly
Trastuzumab-resistant breast cancer cells remain sensitive to the auger electron-emitting radiotherapeutic agent 111In-NLS-trastuzumab and are radiosensitized by methotrexate.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(9):1498-505.
2008: Veerle Kersemans; Bart Cornelissen; Mark D Minden; Joseph Brandwein; Raymond M Reilly
Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequences.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(9):1546-54.
2008: Bart Cornelissen; Kristin McLarty; Veerle Kersemans; Raymond M Reilly
The level of insulin growth factor-1 receptor expression is directly correlated with the tumor uptake of (111)In-IGF-1(E3R) in vivo and the clonogenic survival of breast cancer cells exposed in vitro to trastuzumab (Herceptin).
Nuclear medicine and biology 2008;35(6):645-53.
2008: Zhongli Cai; Zhuo Chen; Kristy E Bailey; Deborah A Scollard; Raymond M Reilly; Katherine A Vallis
Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(8):1353-61.
2008: Danny L Costantini; Meiduo Hu; Raymond M Reilly
Peptide motifs for insertion of radiolabeled biomolecules into cells and routing to the nucleus for cancer imaging or radiotherapeutic applications.
Cancer biotherapy & radiopharmaceuticals 2008;23(1):3-24.
2008: Bart Cornelissen; Kristin McLarty; Veerle Kersemans; Deborah A Scollard; Raymond M Reilly
Properties of [(111)In]-labeled HIV-1 tat peptide radioimmunoconjugates in tumor-bearing mice following intravenous or intratumoral injection.
Nuclear medicine and biology 2008;35(1):101-10.
2007: Meiduo Hu; Deborah A Scollard; Conrad Chan; Paul Chen; Katherine A Vallis; Raymond M Reilly
Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF.
Nuclear medicine and biology 2007;34(8):887-96.
2007: Kristy E Bailey; Danny L Costantini; Zhongli Cai; Deborah A Scollard; Zhuo Chen; Raymond M Reilly; Katherine A Vallis
Epidermal growth factor receptor inhibition modulates the nuclear localization and cytotoxicity of the Auger electron emitting radiopharmaceutical 111In-DTPA human epidermal growth factor.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(9):1562-70.
2007: Danny L Costantini; Conrad Chan; Zhongli Cai; Katherine A Vallis; Raymond M Reilly
(111)In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(8):1357-68.
2007: Raymond M Reilly
Carbon nanotubes: potential benefits and risks of nanotechnology in nuclear medicine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(7):1039-42.
2007: Ying Tang; Shaoxian Yang; Jean Gariépy; Deborah A Scollard; Raymond M Reilly
Construction and evaluation of the tumor imaging properties of 123I-labeled recombinant and enzymatically generated Fab fragments of the TAG-72 monoclonal antibody CC49.
Bioconjugate chemistry 2007;18(3):677-84.
2007: Kristin McLarty; Raymond M Reilly
Molecular imaging as a tool for personalized and targeted anticancer therapy.
Clinical pharmacology and therapeutics 2007;81(3):420-4.
2007: Meiduo Hu; Paul Chen; Judy Wang; Deborah A Scollard; Katherine A Vallis; Raymond M Reilly
123I-labeled HIV-1 tat peptide radioimmunoconjugates are imported into the nucleus of human breast cancer cells and functionally interact in vitro and in vivo with the cyclin-dependent kinase inhibitor, p21(WAF-1/Cip-1).
European journal of nuclear medicine and molecular imaging 2007;34(3):368-77.
2007: Bart Cornelissen; Meiduo Hu; Kristin McLarty; Danny L Costantini; Raymond M Reilly
Cellular penetration and nuclear importation properties of 111In-labeled and 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells.
Nuclear medicine and biology 2007;34(1):37-46.
2007: Veronika Jekerle; Werner Klinkhammer; Raymond M Reilly; Micheline Piquette-Miller; Michael Wiese
Novel tetrahydroisoquinolin-ethyl-phenylamine based multidrug resistance inhibitors with broad-spectrum modulating properties.
Cancer chemotherapy and pharmacology 2007;59(1):61-9.
2006: Veronika Jekerle; Jing-Hung Wang; Deborah A Scollard; Raymond M Reilly; Michael Wiese; Micheline Piquette-Miller
99mTc-Sestamibi, a sensitive probe for in vivo imaging of P-glycoprotein inhibition by modulators and mdr1 antisense oligodeoxynucleotides.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2006;8(6):333-9.
2006: Meiduo Hu; Judy Wang; Paul Chen; Raymond M Reilly
HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Bioconjugate chemistry 2006;17(5):1280-7.
2006: Veronika Jekerle; Werner Klinkhammer; Deborah A Scollard; Kerstin Breitbach; Raymond M Reilly; Micheline Piquette-Miller; Michael Wiese
In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques.
International journal of cancer. Journal international du cancer 2006;119(2):414-22.
2006: Raymond M Reilly; Paul Chen; Judy Wang; Deborah A Scollard; Ross Cameron; Katherine A Vallis
Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(6):1023-31.
2006: Paul Chen; Judy Wang; Kristin Hope; Liqing Jin; John Dick; Ross Cameron; Joseph Brandwein; Mark D Minden; Raymond M Reilly
Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(5):827-36.
2006: Meiduo Hu; Paul Chen; Judy Wang; Conrad Chan; Deborah A Scollard; Raymond M Reilly
Site-specific conjugation of HIV-1 tat peptides to IgG: a potential route to construct radioimmunoconjugates for targeting intracellular and nuclear epitopes in cancer.
European journal of nuclear medicine and molecular imaging 2006;33(3):301-10.
2006: Raymond M Reilly
Radioimmunotherapy of solid tumors: the promise of pretargeting strategies using bispecific antibodies and radiolabeled haptens.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(2):196-9.
2005: Conrad Chan; Jasbir Sandhu; Abhijit Guha; Deborah A Scollard; Judy Wang; Paul Chen; Karen Bai; Lydia Lee; Raymond M Reilly
A human transferrin-vascular endothelial growth factor (hnTf-VEGF) fusion protein containing an integrated binding site for (111)In for imaging tumor angiogenesis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(10):1745-52.
2005: Jing-Hung Wang; Deborah A Scollard; Shirley Teng; Raymond M Reilly; Micheline Piquette-Miller
Detection of P-glycoprotein activity in endotoxemic rats by 99mTc-sestamibi imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(9):1537-45.
2005: Ying Tang; Deborah A Scollard; Paul Chen; Judy Wang; Claire Holloway; Raymond M Reilly
Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [(99m)Tc]-HYNIC-trastuzumab (Herceptin) Fab fragments.
Nuclear medicine communications 2005;26(5):427-32.
2005: Veronika Jekerle; Matthias U Kassack; Raymond M Reilly; Michael Wiese; Micheline Piquette-Miller
Functional comparison of single- and double-stranded mdr1 antisense oligodeoxynucleotides in human ovarian cancer cell lines.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 2005;8(3):516-27.
2005: Ying Tang; Judy Wang; Deborah A Scollard; Hridya Mondal; Claire Holloway; Harriette J Kahn; Raymond M Reilly
Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using (111)In-trastuzumab (Herceptin) Fab fragments.
Nuclear medicine and biology 2005;32(1):51-8.
2004: Ying He; Bikul Das; Sylvain Baruchel; Piyush Kumar; Leonard Wiebe; Raymond M Reilly
Meta-[123I]iodobenzylguanidine is selectively radiotoxic to neuroblastoma cells at concentrations that spare cells of haematopoietic lineage.
Nuclear medicine communications 2004;25(11):1125-30.
2004: J Andrea McCart; Navneet Mehta; Deborah A Scollard; Raymond M Reilly; Jorge Carrasquillo; Nan Tang; Hui Deng; Marshall Miller; Hui Xu; Steven Libutti; H Richard Alexander; David L Bartlett
Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic delivery using 111In-pentetreotide.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;10(3):553-61.
2004: Raymond M Reilly; Deborah A Scollard; Judy Wang; Hridya Mondal; Paul Chen; Lee A Henderson; Barry M Bowen; Katherine A Vallis
A kit formulated under good manufacturing practices for labeling human epidermal growth factor with 111In for radiotherapeutic applications.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(4):701-8.
2004: Yu-Qing Li; Paul Chen; Vipan Jain; Raymond M Reilly; shun wong
Early radiation-induced endothelial cell loss and blood-spinal cord barrier breakdown in the rat spinal cord.
Radiation research 2004;161(2):143-52.
2003: Yu-Qing Li; Paul Chen; Adriana Haimovitz-Friedman; Raymond M Reilly; shun wong
Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation.
Cancer research 2003;63(18):5950-6.
2003: Paul Chen; Ross Cameron; Judy Wang; Katherine A Vallis; Raymond M Reilly
Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(9):1469-78.
2003: Judy Wang; Paul Chen; Marko Mrkobrada; Meiduo Hu; Katherine A Vallis; Raymond M Reilly
Antisense imaging of epidermal growth factor-induced p21(WAF-1/CIP-1) gene expression in MDA-MB-468 human breast cancer xenografts.
European journal of nuclear medicine and molecular imaging 2003;30(9):1273-80.
2002: Judy Wang; Raymond M Reilly; Paul Chen; Shaoxian Yang; Mark R Bray; Jean Gariépy; Conrad Chan; Jasbir Sandhu
Fusion of the CH1 domain of IgG1 to epidermal growth factor (EGF) prolongs its retention in the blood but does not increase tumor uptake.
Cancer biotherapy & radiopharmaceuticals 2002;17(6):665-71.
2002: Katherine A Vallis; Raymond M Reilly; Paul Chen; Amit Oza; Aaron Hendler; Ross Cameron; M Hershkop; Normando Iznaga-Escobar; Mayra Ramos-Suzarte; P Keane
A phase I study of 99mTc-hR3 (DiaCIM), a humanized immunoconjugate directed towards the epidermal growth factor receptor.
Nuclear medicine communications 2002;23(12):1155-64.
2002: Paul Chen; Marko Mrkobrada; Katherine A Vallis; Ross Cameron; Jasbir Sandhu; Aaron Hendler; Raymond M Reilly
Comparative antiproliferative effects of (111)In-DTPA-hEGF, chemotherapeutic agents and gamma-radiation on EGFR-positive breast cancer cells.
Nuclear medicine and biology 2002;29(6):693-9.
2001: Judy Wang; Paul Chen; Z F Su; Katherine A Vallis; Jasbir Sandhu; Ross Cameron; Aaron Hendler; Raymond M Reilly
Amplified delivery of indium-111 to EGFR-positive human breast cancer cells.
Nuclear medicine and biology 2001;28(8):895-902.
2001: Raymond M Reilly; P K Maiti; R Kiarash; A K Prashar; D G Fast; J Entwistle; S A Narang; S Foote; H A Kaplan
Rapid imaging of human melanoma xenografts using an scFv fragment of the human monoclonal antibody H11 labelled with 111In.
Nuclear medicine communications 2001;22(5):587-95.
2000: Raymond M Reilly; R Kiarash; Jasbir Sandhu; Y W Lee; R G Cameron; Aaron Hendler; Katherine A Vallis; Jean Gariépy
A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(5):903-11.
2000: Raymond M Reilly; R Kiarash; R G Cameron; N Porlier; Jasbir Sandhu; R P Hill; Katherine A Vallis; Aaron Hendler; Jean Gariépy
111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(3):429-38.
2000: R J Domingo; Raymond M Reilly
Pre-targeted radioimmunotherapy of human colon cancer xenografts in athymic mice using streptavidin-CC49 monoclonal antibody and 90Y-DOTA-biotin.
Nuclear medicine communications 2000;21(1):89-96.
1998: Raymond M Reilly; Jean Gariépy
Factors influencing the sensitivity of tumor imaging with a receptor-binding radiopharmaceutical.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(6):1036-43.
1997: Raymond M Reilly; R Domingo; Jasbir Sandhu
Oral delivery of antibodies. Future pharmacokinetic trends.
Clinical pharmacokinetics 1997;32(4):313-23.